Projects per year
Personal profile
Monash teaching commitment
HUP3011 - Human pathology: Atherosclerosis
HUP3011 - Human pathology: Vascular biology and disease
IMM3042 - Clinical immunopathology: Recombinant antibodies in immunotherapy
Central Clinical School Honours program "Molecular Imaging Technology"
Biography
Christoph Hagemeyer, a chemist by training, obtained a PhD in Biochemistry from the University of Freiburg (Germany). He made contributions to the field of Cytochrome P450 metabolism in the rodent brain before moving into cardiovascular research developing anti-thrombotic recombinant fusion proteins and novel imaging probes. He migrated to Australia in 2005 and is currently Head of the NanoBiotechnology Laboratory at Monash University’s Australian Centre for Blood Diseases. His main research interests are drug delivery, molecular imaging and novel bioconjugation techniques in thrombosis, inflammation and cancer.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Chemistry, PhD, Albert Ludwigs Universitat Freiburg (Albert Ludwig University of Freiburg)
Award Date: 1 Jun 2001
Chemistry, MSc, Albert Ludwigs Universitat Freiburg (Albert Ludwig University of Freiburg)
Award Date: 1 Apr 1997
External positions
President, Australian Society for Medical Research (ASMR)
22 Nov 2019 → …
NHMRC Senior Research Fellow, National Health and Medical Research Council (NHMRC) (Australia)
1 Jan 2019 → 31 Dec 2023
A/Prof, RMIT University
1 Mar 2014 → …
Research area keywords
- PET CT
- acute MI
- animal models of human disease
- antibodies
- arterial thrombosis
- drug delivery systems
- microbubbles
- molecular imaging
- platelets
- thrombosis
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Novel Thrombolytic Agents for the Treatment of Acute Ischemic Stroke
Hagemeyer, C., Palazzolo, J. S. & Niego, B.
1/01/22 → 31/12/22
Project: Research
-
Self-regulated, glucose-responsive nanomaterials for smart insulin delivery
Hagemeyer, C. & Cavalieri, F.
1/01/20 → 31/12/23
Project: Research
-
-
Single Particle Elemental Analysis – Imaging Mass Cytometer Facility
Ellis, A. V., Bush, A., Mitchell, A., Corbett, A., Reichman, S., Ball, A., Fox, K., Nugegoda, D., Paz Ferreiro, J., Cook, P., Hagemeyer, C., Teo, B. M., Yu, A., Brinkworth, C. & Gray, D.
25/06/20 → 24/06/21
Project: Research
-
Molecular imaging of atrial myopathy: Towards early AF detection and non-invasive disease management
Ezeani, M., Hagemeyer, C. E., Lal, S. & Niego, B., Jan 2022, In: Trends in Cardiovascular Medicine. 32, 1, p. 20-31 12 p.Research output: Contribution to journal › Review Article › Research › peer-review
5 Citations (Scopus) -
Mopping up crystals to keep the blood flowing
Hagemeyer, C. E., Jan 2022, In: EBioMedicine. 75, 2 p., 103786.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access -
A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls
McMahon, J. H., Zerbato, J. M., Lau, J. S. Y., Lange, J. L., Roche, M., Tumpach, C., Dantanarayana, A., Rhodes, A., Chang, J., Rasmussen, T. A., Mackenzie, C. A., Alt, K., Hagenauer, M., Roney, J., O‘Bryan, J., Carey, A., McIntyre, R., Beech, P., O'Keefe, G. J., Wichmann, C. W. & 11 others, , Mar 2021, In: EBioMedicine. 65, 10 p., 103252.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
Collagen-targeted peptides for molecular imaging of diffuse cardiac fibrosis
Ezeani, M., Noor, A., Alt, K., Lal, S., Donnelly, P. S., Hagemeyer, C. E. & Niego, BE., 21 Sep 2021, In: Journal of the American Heart Association. 10, 18, 28 p., e022139.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Effects of water stably-enriched with oxygen as a novel method of tissue oxygenation on mitochondrial function, and as adjuvant therapy for type 2 diabetes in a randomized placebo-controlled trial
Khoo, J., Hagemeyer, C., Henstridge, D. C., Kumble, S., Wang, T-Y., Xu, R., Gani, L., King, T., Soh, S-B., Puar, T., Au, V., Tan, E., Tay, T. L., Kam, C. & Teo, E-K., 14 Jul 2021, In: PLoS ONE. 16, 7, 15 p., e0254619.Research output: Contribution to journal › Article › Research › peer-review
Open Access
Activities
- 2 Editorial responsibility
-
Cardiovascular Therapeutics (Journal)
Christoph Hagemeyer (Associate editor)
2014 → …Activity: Publication peer-review and editorial work types › Editorial responsibility
-
PLoS ONE (Journal)
Christoph Hagemeyer (Associate editor)
2013 → …Activity: Publication peer-review and editorial work types › Editorial responsibility